Navigation Links
Excellent Results Received from GeoVax's Full-Dose HIV/AIDS Vaccine Trial
Date:11/2/2007

se vaccines in already HIV/AIDS infected individuals are being planned.

GeoVax DNA and Recombinant MVA HIV/AIDS vaccines:

-- Use DNA vaccines to "prime" immune responses and MVA vaccines to "boost" immune responses against the AIDS virus

-- Vaccinate against more than 50% of AIDS virus components and cannot cause AIDS

-- Protected 22 of 23 (96%) non-human primates against the development of AIDS for over 3 1/2 years

-- Are manufactured & tested under GMP/GLP - EMEA (EU) and FDA guidelines

-- Satisfactorily completed earlier DNA HIV/AIDS vaccine Phase 1 human trial

-- Are currently being tested in 4 Human Trials. Two started in 2006, two in summer 2007

-- Have been demonstrated safe to date in human trials

-- Are demonstrating positive immune responses against HIV in the majority of vaccine recipients

-- Are in planning stage for a larger Phase 2 human trial in 2008

For further information visit http://www.geovax.com.

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward- looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be determined to be safe for use in humans, GeoVax's vaccines will be effective in preventing AIDS in humans, the vaccines will receive the regulatory approvals necessary to be licensed and marketed, GeoVax can raise the required capital to complete development of its vaccines, there is development of competitive products that may be more effective or easier to use
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
2. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
3. Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
4. Avants Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential
5. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
6. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
7. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
8. Sygnis Pharma AG announces date for presentation of clinical results
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Warner Chilcott plc (Nasdaq: ... Chilcott Corporation (the "Company") has commenced a cash ... the conditions set forth in the Company,s Offer ... 15, 2009 (the "Offer to Purchase"), for any ... notes due 2015 (the "Notes"). ,, The Company ...
(Date:12/15/2009)... LAKE CITY, Dec. 15 Sonic Innovations, ... care services and solutions, donated $10,000 to its ... Monday, Dec. 14, 2009. ,, Sonic Innovations President ... local Feeding America member, the Utah Food Bank, ... Sonic employees also participated in an office food ...
(Date:12/15/2009)... LOUIS, Dec. 15 KV Pharmaceutical ... 2009, the Company received a written notice (the "Notice") ... 7/23/99, a stockholder of the Company, requesting that the ... a record date for stockholder action by written consent ... fill a vacant director seat resulting from Ronald J. ...
Breaking Medicine Technology:Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Sonic Innovations, Inc. Donates $10,000 to Feeding America 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7New discovery reveals fate of nanoparticles in human cells 14221 1New discovery reveals fate of nanoparticles in human cells 14221 2Former Corporate Benefits Manager Sentenced to 57 Months in Prison for Defrauding Health Care Plan of More Than 246 Million Dollars 58097 1Former Corporate Benefits Manager Sentenced to 57 Months in Prison for Defrauding Health Care Plan of More Than 246 Million Dollars 58097 2IEEE USA President endorses national innovation strategy 10050 1
... /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced today that ... International Conference on Antiviral,Research being held in ... virus (HCV) polymerase inhibitor,discovered by Genelabs. , ... D. Roberts,Ph.D., Director of Medicinal Chemistry at ...
... Mo.--(BUSINESS WIRE)--May 4, 2007 - New ... (RRMS),patients treated with COPAXONE(R) (glatiramer acetate ... a,90 percent reduction in magnetic resonance ... baseline. These benefits were,achieved early on ...
Other Medicine Technology:Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... lower strength than needed for protection, CDC says, , , ... doses of H1N1 swine flu vaccine have been recalled ... some potency, federal health officials said Tuesday. , According ... the company,s routine testing of the vaccine for children ... four batches had lower than required potency levels. "This ...
(Date:12/15/2009)... Prostate cancer tests promised but not delivered ... Network calls on Congress to ensure that healthcare ... benefit currently required of insurance companies in 37 ... for those segments of the population and individuals ... American men and men who have a family ...
(Date:12/15/2009)... Knowledge Networks is ... and bio-tech research market with the acquisition ... past 11 years CMR has built and ... (PCN®), which now includes 70,000 U.S. physicians, ... care and hard-to-reach specialties. The Mount-Arlington, ...
(Date:12/15/2009)... N.Y., Dec. 15 Team In Training ... charity sports training program, has reached ... support blood cancer research and patient services. ,, ... the pre-eminent charity endurance sports training program, preparing ... half marathon, triathlon, 100-mile century cycle ride or ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3
... surveillance challenges of world,s largest ... ... FairWarning, Inc., the,world,s leading supplier of cross-platform healthcare ... market leading software,aimed at serving the needs of sophisticated ...
... Pa., Oct. 14 Environmental,Tectonics Corporation,s (Amex: ... (SSG) announced today the receipt of three new ... System (M-138) and two,bulk-sized steam sterilization systems from ... field sterilizer order is a follow-on order from ...
... ECIA) ("Encision," or the "Company"), a medical device company,owning ... of care,in minimally-invasive surgery, announced today that the Company ... common stock to the OTC,Bulletin Board ("OTCBB") and that ... an application to quote the common stock of Encision ...
... DEL MAR, Calif., Oct. 14 An article ... of Anesthesiologists,(ASA) reads:, (Photo: http://www.newscom.com/cgi-bin/prnh/20081014/LATU011 ), ... different approach than,that used in a hospital and ... skill, knowledge base or personality to deal with ...
... Insurance Company Encourages Employers to Use the Fourth Quarter to Review ... ... -- Combined Insurance , a leading provider of supplemental insurance, ... employee benefits and recommends ,Voluntary Benefits, programs as an added incentive ...
... based labeling, packing slip and printing solutions for warehouses, fulfillment ... ... Fort Scott, KS (PRWEB) October 14, 2008 -- My1Stop.com has ... warehouse and distribution centers that present several options for printing ...
Other Medicine News:Health News:FairWarning(R) Announces New Privacy Surveillance Software Release 2Health News:FairWarning(R) Announces New Privacy Surveillance Software Release 3Health News:Environmental Tectonics Corporation's Sterilization Systems Group Announces the Receipt of Three New Contracts 2Health News:Environmental Tectonics Corporation's Sterilization Systems Group Announces the Receipt of Three New Contracts 3Health News:Encision Pursues Transfer of Quotation to OTC Bulletin Board 2Health News:American Society of Anesthesiologists (ASA) 'Wakes Up' to Office-Based Anesthesia (OBA) 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:My1Stop.com Offers Industry Specific Printing, Packing Slip and Labeling Solutions for Warehouse, Fulfillment and Distribution Centers 2Health News:My1Stop.com Offers Industry Specific Printing, Packing Slip and Labeling Solutions for Warehouse, Fulfillment and Distribution Centers 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: